gip/glp-1 drugs Understand GLP-1/GIP Dual Agonist Tirzepatide and Its Effect on Current Weight Loss Therapy The Effects of Dual GLP-1/GIP
Description
Exenatide extended-release (Bydureon BCise) injectable suspension
doi: 10.1016/j.biopsych.2026.05.002 10.1016/j.biopsych.2026.05.002
doi: 10.1111/apt.13662
The GLP-1 receptor agonist dulaglutide attenuates hepatic steatosis in obesity via a weight-independent mechanism
But we do know that its happening and have some solid theories about why
This ensures coordinated care and helps avoid potential interactions
